Preface content

Veterinary vaccine development process: eLearning

      
6-7-hour course
  
£200 ex VAT
       
Internet required
 
Self-directed

   Email us

 

Target audience

The course is primarily aimed at academic researchers having a basic knowledge of virology and vaccinology with more interactive learning materials provided for the early phases of vaccine development during which academia is more involved. However, as it provides a complete overview it will be helpful for anyone wishing to gain an overview of veterinary vaccine development.

Requirements and qualifications

Access to a computer with a reliable internet connection is essential. The course is prepared in English (UK).

Course description

This course provides a complete overview of the different stages of veterinary vaccine development, showing the process of developing a vaccine, how it flows from early-stage research through to commercial development and product registration. Greater awareness of the entire process spanning from early-stage research performed in academia to product development and registration likely performed by a commercial partner is aimed to bridge the knowledge gap between these two sectors.

Computer screenshot taken from Veterinary vaccine development process eLearning course

Learning outcomes

Divided into 6 individual modules, you will be able to:

  • Understand what a Target Product Profile is and how it facilitates vaccine development.
  • Know key questions that should be addressed during the Discovery and Feasibility phase including important technology transfer considerations.
  • Discuss the challenges faced when transferring technologies from academia to industry.
  • Explain the key elements of early- and late-stage veterinary vaccine development.
  • Describe the complexity of product licensing and registration.

Course modules

The course comprises of the following modules:

  • INTRODUCTION
    • Introduction
    • Learning Objectives
  • TARGET PRODUCT PROFILE
    • Target Product Profile
  • VACCINE RESEARCH
    • Discovery & Feasibility
  • VACCINE DEVELOPMENT
    • Early-Phase Development
    • Late-Phase Development
  • PRODUCT LICENCING AND REGULATIONS
    • Product Licencing and Regulations
  • THE PIRBRIGHT INSTITUTE
    • Vaccine Success Stories
  • SUMMARY
    • Summary
    • Glossary of Terms
    • Acknowledgements

Next steps

Contact Pirbright Training for portal access details.

“It was very helpful and informative.”

Trim content

® The Pirbright Institute 2024 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.